Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check4 days agoChange DetectedA new revision label 'Revision: v3.6.2' was added to the record history and the previous label 'Revision: v3.6.0' was removed, updating the page's version history metadata.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision v3.6.0 is added and the previous v3.5.5 revision is removed. The page now includes a notice that the study is no longer looking for participants, indicating recruitment has closed.SummaryDifference0.3%

- Check25 days agoChange DetectedA new revision entry, v3.5.5, was added and the previous entry, v3.5.4, was removed. This reflects a minor update to the page's revision history.SummaryDifference0.1%

- Check47 days agoChange DetectedThe record history now shows a new revision entry, updating from v3.5.3 to v3.5.4. This reflects an incremental update to the page's revision metadata and change tracking.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software revision rather than a change to the ClinicalTrials.gov record history.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded revision: v3.5.2 to the history. Removed revision: v3.5.0 from the history.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.